Open AccessTumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
Author(s) -
Abeer H Abdelhafez,
Benjamin C. Musall,
Beatriz E. Adrada,
Kenneth R. Hess,
Jong Bum Son,
Ken Pin Hwang,
Rosalind P. Candelaria,
Lumarie Santiago,
Gary J. Whitman,
Huong T. LePetross,
Tanya W. Moseley,
Elsa Arribas,
Deanna L. Lane,
Marion E. Scoggins,
Jessica W.T. Leung,
Hagar Mahmoud,
Jason B. White,
Elizabeth Ravenberg,
Jennifer K. Litton,
Vicente Valero,
Peng Wei,
Alastair Thompson,
Stacy L. Moulder,
Mark Pagel,
Jingfei Ma,
Wei Tse Yang,
Gaiane M. Rauch
Publication year - 2020
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-020-05917-7
Subject(s) - medicine , necrosis , breast cancer , neoadjuvant therapy , magnetic resonance imaging , odds ratio , confidence interval , stage (stratigraphy) , effective diffusion coefficient , oncology , cancer , radiology , biology , paleontology
To determine if tumor necrosis by pretreatment breast MRI and its quantitative imaging characteristics are associated with response to NAST in TNBC.